4.6 Article

The new, race-free, Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

期刊

出版社

WALTER DE GRUYTER GMBH
DOI: 10.1515/cclm-2022-0928

关键词

chronic kidney disease epidemiology consortium (CKD-EPI); creatinine; equation; estimated glomerular filtration rate (eGFR); european kidney function consortium (EKFC)

向作者/读者索取更多资源

The EFLM recommends European laboratories to continue using the 2009 version of the CKD-EPI equation without race correction factor. The new EKFC equation, developed from European cohorts, may serve as an alternative equation for estimating GFR in Europe. Estimating equations based on cystatin C may gain popularity due to their independence of race. Reference methods like iohexol clearance for measuring GFR remain necessary in specific patients and/or situations.
The EFLM recommends not to implement the race-free Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation in European laboratories and to keep the 2009 version of the CKD-EPI equation, without applying a race correction factor. This recommendation is completely in line with a recent Editorial published by the European Renal Association who has also proposed to change to a novel equation only when it has considerably better performance, trying to reach global consensus before implementing such a new glomerular filtration rate (GFR) estimation equation. In Europe, this equation could be for instance the new European Kidney Function Consortium (EKFC) equation, which is population-specific, developed from European cohorts and accurate from infants to the older old. Beyond serum creatinine, the estimating equations based on cystatin C will probably gain in popularity, especially because cystatin C seems independent of race. Finally, we must keep in mind that all GFR equations remain an estimation of GFR, especially rough at the individual level. Measuring GFR with a reference method, such as iohexol clearance, remains indicated in specific patients and/or specific situations, and here also, the role of the clinical laboratories is central and should still evolve positively in the future.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据